1 Fujioka, Y & Ishikawa, Y (2009) Remnant lipoproteins as strong key particles to atherogenesis. J Atheroscler Thromb 16, 145–154.
2 Bell, DS, O'Keefe, JH & Jellinger, P (2008) Postprandial dysmetabolism: the missing link between diabetes and cardiovascular events? Endocr Pract 14, 112–124.
3 Le, NA & Walter, MF (2007) The role of hypertriglyceridemia in atherosclerosis. Curr Atheroscler Rep 9, 110–115.
4 Cohn, JS (2006) Postprandial lipemia and remnant lipoproteins. Clin Lab Med 26, 773–786.
5 Collino, M, Patel, NS & Thiemermann, C (2008) PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury. Ther Adv Cardiovasc Dis 2, 179–197.
6 Hernández-Vallejo, SJ, Alqub, M, Luquet, S, et al. (2009) Short-term adaptation of postprandial lipoprotein secretion and intestinal gene expression to a high-fat diet. Am J Physiol Gastrointest Liver Physiol 296, G782–G792.
7 Eberle, D, Hegarty, B, Bossard, P, et al. (2004) SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86, 839–848.
8 Kolehmainen, M, Vidal, H, Alhava, E, et al. (2001) Sterol regulatory element binding protein-1c (SREBP-1c) expression in human obesity. Obes Res 9, 706–712.
9 Magana, MM, Koo, SH, Towle, HC, et al. (2000) Different sterol regulatory element-binding protein-1 isoforms utilize distinct co-regulatory factors to activate the promoter for fatty acid synthase. J Biol Chem 275, 4726–4733.
10 Bełtowski, J (2008) Liver X receptors (LXR) as therapeutic targets in dyslipidemia. Cardiovas Ther 26, 297–316.
11 Yoshikawa, T, Shimano, H, Yahagi, N, et al. (2002) Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J Biol Chem 277, 1705–1711.
12 Repa, JJ, Liang, G, Ou, J, et al. (2000) Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ. Genes Dev 14, 2819–2830.
13 Lalloyer, F, Pedersen, TA, Gross, B, et al. (2009) Rexinoid bexarotene modulates triglyceride but not cholesterol metabolism via gene-specific permissivity of the RXR/LXR heterodimer in the liver. Arterioscler Thromb Vasc Biol 29, 1488–1495.
14 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285, 2486–2497.
15 Grundy, SM (2004) Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 89, 2595–2600.
16 Levine, RL, Garland, D, Oliver, CN, et al. (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186, 464–478.
17 Clarke, SD, Baillie, R, Jump, DB, et al. (1997) Fatty acid regulation of gene expression. Its role in fuel partitioning and insulin resitance. Ann N Y Acad Sci 827, 178–187.
18 Cardona, F, Túnez, I, Tasset, I, et al. (2008) Fat overload aggravates oxidative stress in patients with the metabolic syndrome. Eur J Clin Invest 38, 510–515.
19 Macias-Gonzalez, M, Cardona, F, Queipo-Ortuño, M, et al. (2008) PPARγ mRNA expression is reduced in PBMC after fat overload in patients with metabolic syndrome. J Nutr 138, 903–907.
20 Cardona, F, Tunez, I, Tasset, I, et al. (2008) Similar increase in oxidative stress after fat overload in persons with baseline hypertriglyceridemia with or without the metabolic syndrome. Clin Biochem 41, 701–705.
21 Shimomura, I, Matsuda, M, Hammer, RE, et al. (2000) Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 6, 77–86.
22 Sewter, C, Berger, D, Considine, RV, et al. (2002) Human obesity and type 2 diabetes are associated with alterations in SREBP1 isoform expression that are reproduced ex vivo by tumor necrosis factor-alpha. Diabetes 51, 1035–1041.
23 Diraison, F, Dusserre, E, Vidal, H, et al. (2002) Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity. Am J Physiol Endocrinol Metab 282, E46–E51.
24 Eberlé, D, Hegarty, B, Bossard, P, et al. (2004) SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86, 839–848.
25 Imai, T, Jiang, M, Chambon, P, et al. (2001) Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor alpha mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytes. Proc Natl Acad Sci U S A 98, 224–228.
26 Laffitte, BA, Chao, LC, Li, J, et al. (2003) Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc Natl Acad Sci U S A 100, 5419–5424.
27 Muscat, GE, Wagner, BL, Hou, J, et al. (2002) Regulation of cholesterol homeostasis and lipid metabolism in skeletal muscle by liver X receptors. J Biol Chem 277, 40722–40728.
28 Ferré, P & Foufelle, F (2007) SREBP-1c transcription factor and lipid homeostasis: clinical perspective. Horm Res 68, 72–82.
29 Peet, DJ, Turley, SD, Ma, W, et al. (1998) Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93, 693–704.
30 Hamada, K, Gleason, SL, Levi, BZ, et al. (1989) H-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen response element. Proc Natl Acad Sci U S A 86, 8289–8293.
31 Chen, G, Liang, G, Ou, J, et al. (2004) Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc Natl Acad Sci U S A 101, 11245–11250.
32 Ricote, M, Valledor, AF & Glass, CK (2004) Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis. Arterioscler Thromb Vasc Biol 24, 230–239.
33 Sugden, MC & Holness, MJ (2008) Role of nuclear receptors in the modulation of insulin secretion in lipid induced insulin resistance. Biochem Soc Trans 36, 891–900.